Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chien Chou

Showing results (461-470 of 528) with videos related to

Pageof 53
Sort By:
Haematologica|February 26, 2026
Prognostic implications of myelodysplasia-related gene mutations in <i>NPM1</i>-mutated acute myeloid leukemia: a systematic review and meta-analysisYu-Sung Chang, Yi-Wei Lee, Chieh-Yu Liu, et al.
Blood Cancer Journal|October 13, 2020
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burdenYu-Hung Wang, Chien-Chin Lin, Sze-Hwei Lee, et al.
Oncotarget|November 5, 2017
Germline variations at <i>JAK2</i>, <i>TERT</i>, <i>HBS1L-MYB</i> and <i>MECOM</i> and the risk of myeloproliferative neoplasms in Taiwanese populationYi-Hao Chiang, Yu-Cheng Chang, Huan-Chau Lin, et al.
Blood Cancer Journal|May 31, 2022
Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenibAlexander E Perl, Naoko Hosono, Pau Montesinos, et al.
Plos One|July 25, 2018
Correction: The Critical Role of Early Dengue Surveillance and Limitations of Clinical Reporting - Implications for Non-Endemic CountriesJui-Hung Kao, Chaur-Dong Chen, Zheng-Rong Tiger Li, et al.
American Journal of Hematology|January 2, 2023
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus ClassificationWan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Blood|November 8, 2008
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survivalTiffany Ting-Fang Shih, Hsin-An Hou, Chieh-Yu Liu, et al.
Ejhaem|August 19, 2024
IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivoChien-Chin Lin, Chi-Yuan Yao, Yu-Hung Wang, et al.
BMC Cancer|June 26, 2019
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndromeHuai-Hsuan Huang, Fei-Yun Chen, Wen-Chien Chou, et al.
Hematological Oncology|November 24, 2022
Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromesWan-Hsuan Lee, Chien-Chin Lin, Yu-Hung Wang, et al.
Pageof 53

Showing results (461-470 of 528) with videos related to

Sort By:
Pageof 53
Haematologica|February 26, 2026
Prognostic implications of myelodysplasia-related gene mutations in <i>NPM1</i>-mutated acute myeloid leukemia: a systematic review and meta-analysisYu-Sung Chang, Yi-Wei Lee, Chieh-Yu Liu, et al.
Blood Cancer Journal|October 13, 2020
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burdenYu-Hung Wang, Chien-Chin Lin, Sze-Hwei Lee, et al.
Oncotarget|November 5, 2017
Germline variations at <i>JAK2</i>, <i>TERT</i>, <i>HBS1L-MYB</i> and <i>MECOM</i> and the risk of myeloproliferative neoplasms in Taiwanese populationYi-Hao Chiang, Yu-Cheng Chang, Huan-Chau Lin, et al.
Blood Cancer Journal|May 31, 2022
Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenibAlexander E Perl, Naoko Hosono, Pau Montesinos, et al.
Plos One|July 25, 2018
Correction: The Critical Role of Early Dengue Surveillance and Limitations of Clinical Reporting - Implications for Non-Endemic CountriesJui-Hung Kao, Chaur-Dong Chen, Zheng-Rong Tiger Li, et al.
American Journal of Hematology|January 2, 2023
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus ClassificationWan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Blood|November 8, 2008
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survivalTiffany Ting-Fang Shih, Hsin-An Hou, Chieh-Yu Liu, et al.
Ejhaem|August 19, 2024
IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivoChien-Chin Lin, Chi-Yuan Yao, Yu-Hung Wang, et al.
BMC Cancer|June 26, 2019
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndromeHuai-Hsuan Huang, Fei-Yun Chen, Wen-Chien Chou, et al.
Hematological Oncology|November 24, 2022
Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromesWan-Hsuan Lee, Chien-Chin Lin, Yu-Hung Wang, et al.
Pageof 53